No. As of October 2026, Minapharm Pharmaceuticals SAE (MIPH.CA) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Minapharm Pharmaceuticals SAE does not pass Musaffa's business and financial screening criteria.
Minapharm Pharmaceuticals engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Cairo, Cairo. The company went IPO on 2004-01-11. The Company’s production falls into seven lines, namely Gastroenterology, Ophthalmology, Cardiology, Biogenetics, Dermatology, Dermatology, Orthopedic and Miscellaneous products such as betolvex, broncho-vaxom adult, broncho-vaxom infantile, burinex, chlorhexidine tulle, chlorhexidine tulle, ciloprine, daktacort cream, daktarin cream, desatura, dicynone, among others. Minapharm is in cooperation with several international pharmaceutical companies and it distributes its products within and outside Egypt.
Minapharm Pharmaceuticals SAE MIPH.CA
EGP812.49 EGP32.49 (4.17%) 1D
Last Updated: Oct 01, 12:00 AM·EGX
Pricing for EG stocks is delayed by 24 hours
MIPH.CA Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, Minapharm Pharmaceuticals SAE is classified as not halal.
NOT HALAL
Minapharm Pharmaceuticals SAE (MIPH.CA) Chart
Fetching Price Chart...
Financial Metrics & Statements of Minapharm Pharmaceuticals SAE (MIPH.CA)
FAQ's for Minapharm Pharmaceuticals SAE (MIPH.CA)
As of October 2026, Minapharm Pharmaceuticals SAE MIPH.CA is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Minapharm Pharmaceuticals SAE using these criteria to determine its compliance status.
Muslim investors may consider investing in Minapharm Pharmaceuticals SAE if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Minapharm Pharmaceuticals SAE by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Minapharm Pharmaceuticals SAE may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Minapharm Pharmaceuticals SAE on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Minapharm Pharmaceuticals SAE (MIPH.CA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.